U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07695831) titled 'A Phase 1 Trial of GEN1119 in Participants With Solid Tumors' on July 06.
Brief Summary: The purpose of this trial is to learn about the safety and efficacy of GEN1119 when it is used for the treatment of participants with certain types of cancer.
The trial has multiple parts. The first part of the trial will test different doses of GEN1119 to find out if it is safe and to determine what are the best doses to use. The second part will further refine this optimal dose. The third part continues to test the safety and how well GEN1119 works in additional participants with specific cancer types and at doses chosen based on the results ...